Concepedia

Guido Sabatella

GS

11

Publications

321

Citations

10

H-Index

2002

Active since

Affiliations

Biogen (United States)(Current)

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

University of Milan

Johns Hopkins University

Alexion Pharmaceuticals (United States)

Guido Sabatella is an author at Biogen (United States) specializing in multiple sclerosis, neuroimmunology, and neurodegenerative diseases.

Top concepts

Publications per year

2002–2023

11

Publications

11

Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 <scp>IgG‐Positive NMOSD</scp>

Dean M. Wingerchuk, Kazuo Fujihara, Jacqueline Palace et al. · Annals of Neurology · 2021 · 91 citations · Full text

Proximity of <i>TPR</i> and <i>NTRK1</i> Rearranging Loci in Human Thyrocytes

Emanuela Roccato, Paola Bressan, Guido Sabatella et al. · Cancer Research · 2005 · 50 citations

Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study

Ralph H. B. Benedict, Stanley Cohan, Sharon Lynch et al. · Multiple Sclerosis Journal · 2017 · 44 citations · Full text

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a

June Halper, Diego Centonze, Scott D. Newsome et al. · International Journal of MS Care · 2015 · 22 citations · Full text

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder

Achim Berthele, Michael Levy, Dean M. Wingerchuk et al. · Frontiers in Neurology · 2023 · 22 citations · Full text

Rows per page

1–5 of 11